Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bluebird Bio (NQ: BLUE )

3.000 +0.060 (+2.04%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 25, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,895,793
Open 2.940
Bid (Size) 2.940 (10)
Ask (Size) 3.040 (4)
Prev. Close 2.940
Today's Range 2.890 - 3.050
52wk Range 2.890 - 35.59
Shares Outstanding 67,578,549
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
7 Cheap Biotech Stocks to Buy Now
These biotech stocks can be speculative, but have the potential to blow up in the next couple of years for good gains. 
Via InvestorPlace
Why This Analyst Has 'Little Conviction' On CRISPR's Upcoming Trial Data
 
Via Benzinga

Performance

YTD
-71.70%
-71.70%
1 Month
-27.18%
-27.18%
3 Month
-48.19%
-48.19%
6 Month
-72.12%
-72.12%
1 Year
-90.17%
-90.17%

More News

Read More
Analyst Ratings for bluebird bio
Via Benzinga
bluebird bio Reports First Quarter 2022 Financial Results and Highlights Operational Progress
From bluebird bio, Inc.
Via Business Wire
Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks
Via InvestorPlace
Expert Ratings For bluebird bio
Via Benzinga
Bluebird Bio Joins Layoff Band Wagon As Gene Therapy Biotech Cuts Staff To Reduce Costs
Via Benzinga
92 Biggest Movers From Friday
Via Benzinga
55 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
Via Benzinga
bluebird bio Initiates Restructuring to Reduce Operating Expenses and Advance Near-term Opportunities to Bring Potentially Curative Gene Therapies to Patients in the US
From bluebird bio, Inc.
Via Business Wire
FDA Recommends At Least 15 years Of Follow-Up For Genome Editing Product Trials
Via Benzinga
bluebird bio's Return On Capital Employed Insights
Via Benzinga
76 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Crude Oil Rises Over 3%; Niu Technologies Shares Plunge
Via Benzinga
Expert Ratings For bluebird bio
Via Benzinga
Mid-Day Market Update: Nasdaq Drops 250 Points; Bed Bath & Beyond Shares Surge
Via Benzinga
Why Bluebird Bio Shares Are Tumbling Today
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2022
Via Benzinga
46 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
A Peek Into The Markets: US Stock Futures Tumble; Crude Oil Jumps Over 7%
Via Benzinga
5 Stocks To Watch - Monday, Mar. 7
Via Talk Markets
5 Stocks To Watch For March 7, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.